| Bioactivity | HLA-B*0801-binding EBV peptide is an Epstein-Barr virus (EBV) epitope FLRGRAYGL. HLA-B*0801-binding EBV peptide can bind to the HLA-B*0801 molecule. HLA-B*0801-binding EBV peptide can be presented to CD8+ T cells through HLA-B*0801 to activate a specific immune response[1][2]. |
| CAS | 139143-28-5 |
| Sequence | Phe-Leu-Arg-Gly-Arg-Ala-Tyr-Gly-Leu |
| Shortening | FLRGRAYGL |
| Formula | C49H77N15O11 |
| Molar Mass | 1052.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ely LK, et al. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. J Immunol. 2005 May 1;174(9):5593-601. [2]. Burrows SR, et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med. 1995 Dec 1;182(6):1703-15. |
HLA-B*0801-binding EBV peptide
CAS: 139143-28-5 F: C49H77N15O11 W: 1052.23
HLA-B*0801-binding EBV peptide is an Epstein-Barr virus (EBV) epitope FLRGRAYGL. HLA-B*0801-binding EBV peptide can bind
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.